Pharmakon Advisors Provides $300MM Credit Facility to Coherus BioSciences
Coherus BioSciences entered into a loan agreement with investment funds managed by Pharmakon Advisors. The agreement provides an up to $300 million credit facility, with funds spread across four tranches.
January 10, 2022
Coherus BioSciences | Denny Lanfear | Pharmakon Advisors
Phil Neuffer